US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

UpStream Bio Inc.

5.75

-0.2100-3.52%

Volume:562.41K

Turnover:3.24M

Market Cap:314.93M

PE:-2.00

High:5.86

Open:5.86

Low:5.67

Close:5.96

52wk High:33.68

52wk Low:5.67

Shares:54.77M

Float Shares:46.68M

Volume Ratio:0.67

T/O Rate:1.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8758

EPS(LYR):-2.6636

ROE:-46.05%

ROA:-30.28%

PB:1.16

PE(LYR):-2.16

Loading ...

Overview Company News Filings

Upstream Bio Posts Corporate Presentation Highlighting Verekitug Phase 3 Plans in Severe Asthma, CRSwNP

Upstream Bio Q2 Net Loss Narrows Slightly on Lower R&D Costs

Upstream Bio Inc Q2 Collaboration Revenue USD 773 Thousand

THOMSON REUTERS

Press Release: Onity Group Announces Second Quarter 2026 Results

Upstream Bio Inc Expected to Post a Loss of 76 Cents a Share - Earnings Preview

Arbor Realty Trust Reports Second Quarter 2026 Results and Declares Dividend of $0.17 per Share

Top Executive Makes Strategic Move With Upstream Bio Stock

Upstream Bio presents new responder analyses from VIBRANT trial of verekitug

Upstream Bio says Phase 2 VIBRANT trial shows verekitug improves nasal polyp score in about 80% of CRSwNP patients

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in Crswnp in Significant Majority of Participants Treated With Verekitug in the Phase 2 Vibrant Trial at Eaaci 2026

THOMSON REUTERS

Upstream Bio Inc : JP Morgan Cuts to Neutral From Overweight; Cuts Target Price to $8 From $35

THOMSON REUTERS

Upstream Bio Shareholders Elect Directors, Ratify 2026 Auditor

Upstream Bio shareholders elect Fleming, Ratcliffe as Class II directors

Upstream Bio to Showcase Additional Efficacy Data From the Phase 2 Vibrant Trial of Verekitug in Crswnp in Oral Session at Eaaci 2026

THOMSON REUTERS

Upstream Bio Initiated at Buy by HC Wainwright & Co.

Upstream Bio CEO to join Goldman Sachs Global Healthcare Conference fireside chat

Upstream Bio initiated with a Buy at H.C. Wainwright

Upstream Bio, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating

THOMSON REUTERS

Analysts’ Top Healthcare Picks: Upstream Bio, Inc. (UPB), Plus Therapeutics (PSTV)

Upstream Bio presents data from Phase 2 VIBRANT trial of verekitug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/UPB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"UPB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UPB\",,,,,undefined,":{"symbol":"UPB","market":"US","secType":"STK","nameCN":"UpStream Bio Inc.","latestPrice":5.75,"timestamp":1789070400000,"preClose":5.96,"halted":0,"volume":562410,"delay":0,"changeRate":-0.03523489932885906,"floatShares":46680775,"shares":54771041,"eps":-2.875781,"marketStatus":"Pre-Mkt","change":-0.21,"latestTime":"09-11 05:03:19 EDT","open":5.86,"high":5.86,"low":5.67,"amount":3237718.725855,"amplitude":0.031879,"askPrice":7,"askSize":100,"bidPrice":4.85,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.875781,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":5.75,"postHourTrading":{"tag":"盘后","latestPrice":5.75,"preClose":5.75,"latestTime":"19:30 EDT","volume":30505,"amount":175403.12,"timestamp":1789083005972,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6712509202405409,"impliedVol":3.3501,"impliedVolPercentile":0.924},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UPB\",,,,,undefined,":{"symbol":"UPB","floatShares":46680775,"roa":"-30.28%","roe":"-46.05%","lyrEps":-2.663615,"volumeRatio":0.6712509202405409,"shares":54771041,"dividePrice":0,"high":5.86,"amplitude":0.031879,"preClose":5.96,"low":5.67,"week52Low":5.67,"pbRate":"1.16","psRate":"99.73","week52High":33.68,"institutionHeld":0,"latestPrice":5.75,"eps":-2.875781,"divideRate":0,"volume":562410,"delay":0,"ttmEps":-2.875781,"open":5.86,"prevYearClose":27.15,"prevWeekClose":6.01,"prevMonthClose":6.62,"prevQuarterClose":6.92,"fiveDayClose":6.48,"twentyDayClose":6.91,"sixtyDayClose":6.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/UPB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"UPB","fiscalQuarterEnding":"2026/06","expectedEps":-0.78,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.73},{"market":"US","date":"2026-05-13","symbol":"UPB","fiscalQuarterEnding":"2026/03","expectedEps":-0.8,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2026-03-26","symbol":"UPB","fiscalQuarterEnding":"2025/12","expectedEps":-0.73,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"pre","actualEps":-0.79},{"market":"US","date":"2025-05-06","symbol":"UPB","fiscalQuarterEnding":"2025/03","expectedEps":-0.49,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-0.51},{"market":"US","date":"2025-03-12","symbol":"UPB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"UPB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"UPB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.625,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1781323200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/UPB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"UPB","date":"2026-09-10","current":-1.999457,"percent":0.997904,"low":-36.237602,"twenty":-12.746327,"median":-7.949104,"eighty":-3.469088,"high":-2.055104,"avg":-9.395102,"sd":7.008581,"marketCap":326435404},"quantilePoints":[{"date":"2024-10-11","current":-21.547111,"twenty":-21.096119,"median":-20.419631,"eighty":-19.743142,"marketCap":872808815},{"date":"2024-10-18","current":-29.91246,"twenty":-29.856691,"median":-29.151973,"eighty":-22.814588,"marketCap":1211664002},{"date":"2024-10-25","current":-33.154958,"twenty":-33.128498,"median":-29.931472,"eighty":-28.137991,"marketCap":1343007876},{"date":"2024-10-31","current":-32.943274,"twenty":-33.154958,"median":-32.429578,"eighty":-29.151973,"marketCap":1334433205},{"date":"2024-11-08","current":-35.748083,"twenty":-33.28726,"median":-32.943274,"eighty":-29.633615,"marketCap":1448047598},{"date":"2024-11-15","current":-26.036965,"twenty":-33.27403,"median":-32.40745,"eighty":-26.47861,"marketCap":1390295829},{"date":"2024-11-22","current":-17.866537,"twenty":-33.154958,"median":-29.91246,"eighty":-25.555171,"marketCap":954019497},{"date":"2024-11-29","current":-21.951751,"twenty":-33.154958,"median":-29.151973,"eighty":-21.870823,"marketCap":1172157663},{"date":"2024-12-06","current":-22.082237,"twenty":-33.144374,"median":-26.689395,"eighty":-21.903572,"marketCap":1179125222},{"date":"2024-12-13","current":-20.486294,"twenty":-33.088806,"median":-26.036965,"eighty":-21.589777,"marketCap":1093906626},{"date":"2024-12-20","current":-16.672089,"twenty":-32.969734,"median":-24.742143,"eighty":-20.201232,"marketCap":890239542},{"date":"2024-12-27","current":-19.517686,"twenty":-32.858694,"median":-23.382078,"eighty":-19.472518,"marketCap":1042185906},{"date":"2025-01-03","current":-16.36093,"twenty":-32.784605,"median":-22.553994,"eighty":-19.153329,"marketCap":873624596},{"date":"2025-01-10","current":-16.250519,"twenty":-32.617811,"median":-22.077219,"eighty":-18.486847,"marketCap":867728970},{"date":"2025-01-17","current":-10.92067,"twenty":-31.635576,"median":-21.951751,"eighty":-17.320504,"marketCap":583131018},{"date":"2025-01-24","current":-10.810259,"twenty":-29.950484,"median":-21.600443,"eighty":-16.501454,"marketCap":577235392},{"date":"2025-01-31","current":-11.041119,"twenty":-29.91246,"median":-20.852659,"eighty":-16.230444,"marketCap":589562611},{"date":"2025-02-07","current":-8.561886,"twenty":-29.633615,"median":-19.703378,"eighty":-11.472726,"marketCap":457179006},{"date":"2025-02-14","current":-7.3574,"twenty":-29.151973,"median":-19.472518,"eighty":-10.92067,"marketCap":392863085},{"date":"2025-02-21","current":-8.260764,"twenty":-28.137991,"median":-19.276941,"eighty":-10.810259,"marketCap":441100026},{"date":"2025-02-28","current":-7.839194,"twenty":-27.097043,"median":-19.030874,"eighty":-9.965112,"marketCap":418589453},{"date":"2025-03-07","current":-8.451474,"twenty":-26.562924,"median":-18.338294,"eighty":-8.834903,"marketCap":451283380},{"date":"2025-03-14","current":-7.737899,"twenty":-26.318012,"median":-17.866537,"eighty":-8.491624,"marketCap":485986508},{"date":"2025-03-21","current":-6.875286,"twenty":-26.085144,"median":-16.857781,"eighty":-8.411325,"marketCap":431809204},{"date":"2025-03-28","current":-5.816236,"twenty":-26.012875,"median":-16.36093,"eighty":-8.168077,"marketCap":365294494},{"date":"2025-04-04","current":-5.380659,"twenty":-25.645507,"median":-16.240482,"eighty":-7.936302,"marketCap":337937638},{"date":"2025-04-11","current":-5.466066,"twenty":-24.254326,"median":-13.751211,"eighty":-7.734483,"marketCap":343301728},{"date":"2025-04-17","current":-7.191293,"twenty":-23.886958,"median":-11.472726,"eighty":-7.5722,"marketCap":451656335},{"date":"2025-04-25","current":-7.652492,"twenty":-23.286723,"median":-11.041119,"eighty":-7.514132,"marketCap":480622419},{"date":"2025-05-02","current":-7.693506,"twenty":-22.857123,"median":-10.850408,"eighty":-7.502769,"marketCap":483198327},{"date":"2025-05-09","current":-6.005612,"twenty":-22.499792,"median":-10.810259,"eighty":-7.378434,"marketCap":475536334},{"date":"2025-05-16","current":-5.964849,"twenty":-22.162536,"median":-10.288315,"eighty":-7.189481,"marketCap":472308712},{"date":"2025-05-23","current":-6.324914,"twenty":-22.076215,"median":-9.921951,"eighty":-6.77963,"marketCap":500819374},{"date":"2025-05-30","current":-6.352089,"twenty":-22.02402,"median":-9.013568,"eighty":-6.524152,"marketCap":502971123},{"date":"2025-06-06","current":-7.357554,"twenty":-21.951751,"median":-8.668839,"eighty":-6.524152,"marketCap":582585803},{"date":"2025-06-13","current":-7.853492,"twenty":-21.855392,"median":-8.531773,"eighty":-6.551855,"marketCap":621855206},{"date":"2025-06-20","current":-7.228474,"twenty":-21.688772,"median":-8.441437,"eighty":-6.588317,"marketCap":572364999},{"date":"2025-06-27","current":-7.432284,"twenty":-21.589777,"median":-8.421362,"eighty":-6.683973,"marketCap":588503110},{"date":"2025-07-03","current":-7.60892,"twenty":-21.547111,"median":-8.293047,"eighty":-6.875286,"marketCap":602489473},{"date":"2025-07-11","current":-8.043715,"twenty":-21.219023,"median":-8.229183,"eighty":-7.004282,"marketCap":636917443},{"date":"2025-07-18","current":-7.500221,"twenty":-20.486294,"median":-8.00983,"eighty":-7.116503,"marketCap":593882481},{"date":"2025-07-25","current":-9.06956,"twenty":-20.325696,"median":-7.964314,"eighty":-7.165671,"marketCap":718145935},{"date":"2025-08-01","current":-10.401121,"twenty":-19.703378,"median":-8.043715,"eighty":-7.186764,"marketCap":823581592},{"date":"2025-08-08","current":-8.173881,"twenty":-19.517686,"median":-8.19076,"eighty":-7.191293,"marketCap":853925323},{"date":"2025-08-15","current":-9.608438,"twenty":-19.472518,"median":-8.256445,"eighty":-7.228474,"marketCap":1003793530},{"date":"2025-08-22","current":-9.154334,"twenty":-19.472518,"median":-8.332111,"eighty":-7.228474,"marketCap":956353234},{"date":"2025-08-29","current":-8.648626,"twenty":-19.29215,"median":-8.429698,"eighty":-7.242061,"marketCap":903521996},{"date":"2025-09-05","current":-10.155428,"twenty":-19.267816,"median":-8.442215,"eighty":-7.274671,"marketCap":1060937523},{"date":"2025-09-12","current":-9.247219,"twenty":-19.117195,"median":-8.531282,"eighty":-7.282823,"marketCap":966056931},{"date":"2025-09-19","current":-8.911801,"twenty":-19.040911,"median":-8.561886,"eighty":-7.298422,"marketCap":931015804},{"date":"2025-09-26","current":-8.416414,"twenty":-18.814066,"median":-8.561394,"eighty":-7.303028,"marketCap":879262754},{"date":"2025-10-03","current":-9.592957,"twenty":-18.486847,"median":-8.591998,"eighty":-7.324944,"marketCap":1002176247},{"date":"2025-10-10","current":-10.212191,"twenty":-18.290115,"median":-8.630565,"eighty":-7.351996,"marketCap":1066867560},{"date":"2025-10-17","current":-11.4971,"twenty":-18.113457,"median":-8.648626,"eighty":-7.357523,"marketCap":1201102033},{"date":"2025-10-24","current":-10.903668,"twenty":-17.908694,"median":-8.694854,"eighty":-7.362988,"marketCap":1139106192},{"date":"2025-10-31","current":-13.298037,"twenty":-17.320504,"median":-8.903157,"eighty":-7.366819,"marketCap":1389245933},{"date":"2025-11-07","current":-10.460565,"twenty":-17.071577,"median":-8.919541,"eighty":-7.375835,"marketCap":1278553063},{"date":"2025-11-14","current":-10.319087,"twenty":-16.746366,"median":-8.953083,"eighty":-7.3842,"marketCap":1261260713},{"date":"2025-11-21","current":-11.035322,"twenty":-16.535581,"median":-9.042102,"eighty":-7.390371,"marketCap":1348803231},{"date":"2025-11-28","current":-12.644639,"twenty":-16.41714,"median":-9.068084,"eighty":-7.395598,"marketCap":1545503702},{"date":"2025-12-05","current":-12.264416,"twenty":-16.306728,"median":-9.154334,"eighty":-7.402392,"marketCap":1499030514},{"date":"2025-12-12","current":-12.145044,"twenty":-16.258549,"median":-9.253501,"eighty":-7.413262,"marketCap":1484440094},{"date":"2025-12-19","current":-13.201711,"twenty":-16.238474,"median":-9.412348,"eighty":-7.419454,"marketCap":1613592327},{"date":"2025-12-26","current":-13.38298,"twenty":-16.206354,"median":-9.577476,"eighty":-7.422171,"marketCap":1635748149},{"date":"2026-01-02","current":-12.003565,"twenty":-15.686418,"median":-9.608438,"eighty":-7.426849,"marketCap":1467147745},{"date":"2026-01-09","current":-12.175992,"twenty":-13.691713,"median":-9.623919,"eighty":-7.437719,"marketCap":1488222796},{"date":"2026-01-16","current":-13.661516,"twenty":-14.223893,"median":-9.706483,"eighty":-7.459459,"marketCap":1669792461},{"date":"2026-01-23","current":-14.055003,"twenty":-14.055003,"median":-9.763246,"eighty":-7.459459,"marketCap":1717886807},{"date":"2026-01-30","current":-13.679201,"twenty":-14.055003,"median":-9.837934,"eighty":-7.487886,"marketCap":1671954005},{"date":"2026-02-06","current":-11.495127,"twenty":-13.997527,"median":-9.967119,"eighty":-7.498759,"marketCap":1405003366},{"date":"2026-02-13","current":-5.659139,"twenty":-13.966579,"median":-10.045793,"eighty":-7.487886,"marketCap":691693964},{"date":"2026-02-20","current":-3.775707,"twenty":-13.794285,"median":-9.921951,"eighty":-7.430925,"marketCap":461489567},{"date":"2026-02-27","current":-3.49275,"twenty":-13.743121,"median":-9.768407,"eighty":-7.40375,"marketCap":426904868},{"date":"2026-03-06","current":-3.391062,"twenty":-13.712802,"median":-9.724309,"eighty":-7.375835,"marketCap":414475992},{"date":"2026-03-13","current":-4.171405,"twenty":-13.705728,"median":-9.63424,"eighty":-7.351996,"marketCap":509854106},{"date":"2026-03-20","current":-3.704968,"twenty":-13.684506,"median":-9.611018,"eighty":-7.282823,"marketCap":452843392},{"date":"2026-03-27","current":-3.71417,"twenty":-13.665053,"median":-9.577476,"eighty":-7.221038,"marketCap":532771662},{"date":"2026-04-02","current":-3.532065,"twenty":-13.632336,"median":-9.412348,"eighty":-7.146004,"marketCap":506650069},{"date":"2026-04-10","current":-3.953182,"twenty":-13.517385,"median":-9.253501,"eighty":-6.612231,"marketCap":567056254},{"date":"2026-04-17","current":-3.831779,"twenty":-13.45372,"median":-9.154334,"eighty":-6.50272,"marketCap":549641858},{"date":"2026-04-24","current":-3.642087,"twenty":-13.411276,"median":-9.068084,"eighty":-6.341219,"marketCap":522431865},{"date":"2026-05-01","current":-3.482746,"twenty":-13.38298,"median":-9.030487,"eighty":-6.247466,"marketCap":499575471},{"date":"2026-05-08","current":-3.408766,"twenty":-13.356783,"median":-8.950503,"eighty":-6.042298,"marketCap":488963574},{"date":"2026-05-15","current":-3.051413,"twenty":-13.336336,"median":-8.911801,"eighty":-5.873814,"marketCap":478351676},{"date":"2026-05-22","current":-2.936855,"twenty":-13.312561,"median":-8.871357,"eighty":-5.82388,"marketCap":460393081},{"date":"2026-05-29","current":-2.888254,"twenty":-13.287802,"median":-8.694854,"eighty":-5.684399,"marketCap":452774283},{"date":"2026-06-05","current":-2.579294,"twenty":-13.258302,"median":-8.648626,"eighty":-5.496812,"marketCap":404340495},{"date":"2026-06-12","current":-2.214791,"twenty":-13.222933,"median":-8.630565,"eighty":-5.216676,"marketCap":347199510},{"date":"2026-06-18","current":-2.134948,"twenty":-13.191984,"median":-8.604831,"eighty":-4.257618,"marketCap":334682913},{"date":"2026-06-26","current":-2.207848,"twenty":-13.129203,"median":-8.561886,"eighty":-4.092265,"marketCap":346111110},{"date":"2026-07-02","current":-2.527222,"twenty":-13.033705,"median":-8.501661,"eighty":-3.922831,"marketCap":396177498},{"date":"2026-07-10","current":-2.71121,"twenty":-12.989493,"median":-8.446844,"eighty":-3.831779,"marketCap":425020090},{"date":"2026-07-17","current":-2.509865,"twenty":-12.97623,"median":-8.429698,"eighty":-3.775707,"marketCap":393456498},{"date":"2026-07-24","current":-2.221734,"twenty":-12.962966,"median":-8.408673,"eighty":-3.733139,"marketCap":348287910},{"date":"2026-07-31","current":-2.280749,"twenty":-12.929663,"median":-8.332111,"eighty":-3.686663,"marketCap":357539308},{"date":"2026-08-07","current":-2.384893,"twenty":-12.91308,"median":-8.260764,"eighty":-3.654227,"marketCap":373865303},{"date":"2026-08-14","current":-2.418325,"twenty":-12.836708,"median":-8.229183,"eighty":-3.58648,"marketCap":378467893},{"date":"2026-08-21","current":-2.397327,"twenty":-12.813742,"median":-8.043715,"eighty":-3.543056,"marketCap":375181630},{"date":"2026-08-28","current":-2.376328,"twenty":-12.809108,"median":-7.975124,"eighty":-3.522202,"marketCap":371895368},{"date":"2026-09-04","current":-2.127846,"twenty":-12.758706,"median":-7.949605,"eighty":-3.486539,"marketCap":333007929},{"date":"2026-09-10","current":-2.085849,"twenty":-12.746327,"median":-7.949104,"eighty":-3.469088,"marketCap":326435404}],"updateTime":1789117399976},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"UPB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658992214","title":"Upstream Bio Posts Corporate Presentation Highlighting Verekitug Phase 3 Plans in Severe Asthma, CRSwNP","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992214","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992214?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:24","pubTimestamp":1786447458,"startTime":"0","endTime":"0","summary":"Upstream Bio posts corporate presentation highlighting verekitug Phase 3 plans in severe asthma, CRSwNPUpstream Bio outlined plans to meet FDA in mid-2026, with Phase 3 starts in severe asthma and CRS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL1Q1xvk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992965","title":"Upstream Bio Q2 Net Loss Narrows Slightly on Lower R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992965","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992965?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:14","pubTimestamp":1786446875,"startTime":"0","endTime":"0","summary":"Upstream Bio Q2 net loss narrows slightly on lower R&D costsOverviewUS biotech firm reported Q2 collaboration revenue declined yr/yrQ2 net loss narrowed slightly from same period last yrCompany comple","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","MGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994461","title":"Upstream Bio Inc Q2 Collaboration Revenue USD 773 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994461","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994461?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLX20FP6J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657680830","title":"Press Release: Onity Group Announces Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657680830","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657680830?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:45","pubTimestamp":1786013100,"startTime":"0","endTime":"0","summary":"-- Adjusted pre-tax income* of $14 million, resulting in annualized adjusted. -- Net loss includes $9 million pre-tax cost related to reverse asset sale. and legacy subservicing transfer and $24 million pre-tax unfavorable. -- $283 million in total revenue, up 15% vs Q2 2025; $281 million in. -- $42 billion in total servicing additions, including quarterly record of. over $15 billion in Originations, up 64% vs Q2 2025; $341 billion in. ending servicing UPB, up 10% vs Q2 20252026 Outlook:-- Maintained adjusted ROE* guidance range at 10% - 15%, expected to be at. the lower end of the range, in light of persistent geopolitical. -- Reaffirming previous guidance on servicing UPB growth, MSR hedge. reverse assets; sold approximately 80% of reverse MSRs, based on fair","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMLP","TPZ","UPB","BK4561","EIPX","AMLP","AMZA","USAI","ENFR","BK4144","BK4590","ET","TNGY","MLPA","BK4581","EIPI","BK4588","MDST","BK4229","ONIT","BK4139","BK4585","UMI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655649193","title":"Upstream Bio Inc Expected to Post a Loss of 76 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2655649193","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655649193?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:52","pubTimestamp":1785505927,"startTime":"0","endTime":"0","summary":"Upstream Bio Inc <UPB.OQ> expected to post a loss of76cents a share - Earnings PreviewUpstream Bio IncUPB.OQUPB.Ois expected to  show a fall in quarterly revenue when it reports  results on August 4 (","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X24F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655361378","title":"Arbor Realty Trust Reports Second Quarter 2026 Results and Declares Dividend of $0.17 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2655361378","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655361378?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:30","pubTimestamp":1785501000,"startTime":"0","endTime":"0","summary":"Company Highlights: GAAP net loss of $(37.3) million, or $(0.20) per diluted common shareDistributable earnings1 of $0.10 per diluted common share, or $0.15 excluding $9.6 million of net realized loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/31/3336797/0/en/Arbor-Realty-Trust-Reports-Second-Quarter-2026-Results-and-Declares-Dividend-of-0-17-per-Share.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DECU","RGLO","JOYT","PMDE","BK4139","VGFPF","ABR","FEBU","VOTE","UPB","BK4110","GXDW","REET","HYIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644897776","title":"Top Executive Makes Strategic Move With Upstream Bio Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2644897776","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644897776?lang=en_us&edition=fundamental","pubTime":"2026-06-18 10:10","pubTimestamp":1781748658,"startTime":"0","endTime":"0","summary":"New insider activity at Upstream Bio, Inc. ( ($UPB) ) has taken place on June 17, 2026. CEO Sutherland Everett Rand has recently sold 2,095 shares ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-strategic-move-with-upstream-bio-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-strategic-move-with-upstream-bio-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643324775","title":"Upstream Bio presents new responder analyses from VIBRANT trial of verekitug","url":"https://stock-news.laohu8.com/highlight/detail?id=2643324775","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643324775?lang=en_us&edition=fundamental","pubTime":"2026-06-15 04:55","pubTimestamp":1781470554,"startTime":"0","endTime":"0","summary":"Upstream Bio (UPB) presented new responder analyses from the Phase 2 VIBRANT trial of verekitug in participants with chronic rhinosinusitis with na...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/upstream-bio-presents-new-responder-analyses-from-vibrant-trial-of-verekitug-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/upstream-bio-presents-new-responder-analyses-from-vibrant-trial-of-verekitug-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643714241","title":"Upstream Bio says Phase 2 VIBRANT trial shows verekitug improves nasal polyp score in about 80% of CRSwNP patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2643714241","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643714241?lang=en_us&edition=fundamental","pubTime":"2026-06-14 22:00","pubTimestamp":1781445622,"startTime":"0","endTime":"0","summary":"Upstream Bio presented new post-hoc responder analyses from its Phase 2 VIBRANT trial of verekitug in chronic rhinosinusitis with nasal polyps at EAACI 2026.Quarterly dosing drove clinically meaningful symptom improvement for most treated participants, supporting a differentiated efficacy profile in severe, inadequately controlled disease.Management flagged plans to move into Phase 3 trials in CRSwNP, with a parallel Phase 3 program in severe asthma targeted for Q1 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260614:nNDL1DSxs7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","UPB","IE00B64PRP62.GBP","BK4588","LU2095319765.USD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","SG9999014021.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","LU0314104364.USD","SG9999014039.USD","IE00BN0W2V16.EUR","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643241272","title":"Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in Crswnp in Significant Majority of Participants Treated With Verekitug in the Phase 2 Vibrant Trial at Eaaci 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643241272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643241272?lang=en_us&edition=fundamental","pubTime":"2026-06-14 22:00","pubTimestamp":1781445600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260614:nTUA1QTH4F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642889254","title":"Upstream Bio Inc : JP Morgan Cuts to Neutral From Overweight; Cuts Target Price to $8 From $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2642889254","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642889254?lang=en_us&edition=fundamental","pubTime":"2026-06-12 12:55","pubTimestamp":1781240111,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42J0VK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642479907","title":"Upstream Bio Shareholders Elect Directors, Ratify 2026 Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2642479907","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642479907?lang=en_us&edition=fundamental","pubTime":"2026-06-11 05:04","pubTimestamp":1781125470,"startTime":"0","endTime":"0","summary":"An announcement from Upstream Bio, Inc. ( ($UPB) ) is now available. Upstream Bio, Inc. held its 2026 Annual Meeting of Stockholders on June 9, 202...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/upstream-bio-shareholders-elect-directors-ratify-2026-auditor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/upstream-bio-shareholders-elect-directors-ratify-2026-auditor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642447511","title":"Upstream Bio shareholders elect Fleming, Ratcliffe as Class II directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642447511","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642447511?lang=en_us&edition=fundamental","pubTime":"2026-06-11 04:06","pubTimestamp":1781121973,"startTime":"0","endTime":"0","summary":"Upstream Bio held its annual shareholder meeting on June 9, 2026.Shareholders backed the selection of H. Edward Fleming Jr. and Liam Ratcliffe as Class II directors, setting terms through the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Upstream Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL5ThXcp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486542","title":"Upstream Bio to Showcase Additional Efficacy Data From the Phase 2 Vibrant Trial of Verekitug in Crswnp in Oral Session at Eaaci 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641486542?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUAXTDQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640490123","title":"Upstream Bio Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2640490123","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640490123?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:12","pubTimestamp":1780488720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/UPB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 03, 2026 08:12 ET (12:12 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640090643","title":"Upstream Bio CEO to join Goldman Sachs Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2640090643","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640090643?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:05","pubTimestamp":1780484716,"startTime":"0","endTime":"0","summary":"Upstream Bio CEO Rand Sutherland will join a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026.The session is scheduled for 10:40 a.m. ET.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL5slpyr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","LU2237443978.SGD","LU0345770993.USD","LU0061475181.USD","LU2210150020.SGD","IE00B64PRP62.GBP","LU0742534661.SGD","SG9999014021.USD","IE0002270589.USD","IE0004086264.USD","LU1668664300.SGD","LU2095319765.USD","LU0096364046.USD","LU1868837136.USD","LU0942090050.USD","LU2265009873.SGD","IE0034235188.USD","BK4516","LU0251131958.USD","LU2750360641.GBP","IE00BGHQF748.EUR","LU2237443895.HKD","LU0251142724.SGD","BK4533","LU0868494617.USD","IE00BSNM7G36.USD","LU0345770308.USD","LU2471134879.HKD","NDAQ","LU0106831901.USD","IE00B3QW5Z07.USD","BK4585","LU1791807156.HKD","GSX","LU1894683348.USD","LU1868836914.USD","LU2237443382.USD","LU2471134796.USD","UPB","BK4588","LU1868837300.USD","LU0048573561.USD","GS","IE00BN0W2W23.USD","LU1868836591.USD","SG9999014039.USD","IE00BN0W2V16.EUR","LU0868494708.USD","LU1894683264.USD","LU2471134952.CNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640903722","title":"Upstream Bio initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2640903722","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640903722?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:11","pubTimestamp":1780481467,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Matthew Caufield initiated coverage of Upstream Bio (UPB) with a Buy rating and $36 price target The company’s lead biologi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/upstream-bio-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/upstream-bio-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640903689","title":"Upstream Bio, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2640903689","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640903689?lang=en_us&edition=fundamental","pubTime":"2026-06-03 18:03","pubTimestamp":1780481019,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nAZN4T0AFY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636022854","title":"Analysts’ Top Healthcare Picks: Upstream Bio, Inc. (UPB), Plus Therapeutics (PSTV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636022854","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636022854?lang=en_us&edition=fundamental","pubTime":"2026-05-19 21:50","pubTimestamp":1779198607,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Upstream Bio, Inc. (UPB) and Plus Therapeutics (PSTV...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-upstream-bio-inc-upb-plus-therapeutics-pstv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-upstream-bio-inc-upb-plus-therapeutics-pstv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","BK4139","LU0029874061.USD","LU0128526141.USD","BK4588","BK4137","BK4581","PSTV","UPB","BK4585","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636775850","title":"Upstream Bio presents data from Phase 2 VIBRANT trial of verekitug","url":"https://stock-news.laohu8.com/highlight/detail?id=2636775850","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636775850?lang=en_us&edition=fundamental","pubTime":"2026-05-18 23:35","pubTimestamp":1779118526,"startTime":"0","endTime":"0","summary":"Upstream Bio (UPB) presented new data from the Phase 2 VIBRANT trial evaluating verekitug in participants with chronic rhinosinusitis with nasal po...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/upstream-bio-presents-data-from-phase-2-vibrant-trial-of-verekitug-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/upstream-bio-presents-data-from-phase-2-vibrant-trial-of-verekitug-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":73,"code":"91000000","status":"200"}]}}